Category: Health Care Costs

Transparency and High-Value Health Care

As the following examples show, efforts to arm patients with reliable quality and cost data to shop wisely for health care services will have a meaningful impact on bending the current, unsustainable health care cost curve. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

New issue brief on empowering consumers

Whether it’s a cost calculator or a mobile app, health plans provide consumers with a wide-range of tools that allow individuals to easily compare data on estimated costs of certain procedures and treatments as well as quality measures so they can make informed choices when selecting a provider or hospital. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

What do consumers really think about drug prices?

Echoing June’s Kaiser Health Tracking Poll, the latest survey again shows a large majority of consumers (72 percent) – especially those currently taking prescription drugs (77 percent) – say the cost of medical treatments is unreasonable. Continue reading

Posted in: Cost Alert, Health Care Costs

Stakeholders agree: We need generic competition

Recent proposals to extend market exclusivity for brand-name medications would delay generic competition and have a dangerous effect on pharmaceutical costs – pushing prices higher and higher. Continue reading

Posted in: AHIP Letters, Health Care Costs

Hospital conglomerates: ‘The trend is concerning’

Decreased competition among providers, and higher prices and fewer choices for health care consumers are among the dangers posed by hospital consolidation, leading physicians at Johns Hopkins University cautioned in a new Journal of the American Medical Association article. Continue reading

Posted in: Health Care Costs

Everyone knows drug prices are a problem … except pharma

Health care experts, physicians, researchers, health plans, policymakers, Medicaid directors, patients – they all recognize how dangerous dramatic drug price increases are becoming for our patients and our health care system. As this week’s news coverage showed, pharmaceutical companies are still oblivious to how their six-figure price tags affect patients who need lifesaving treatments. Continue reading

Posted in: Health Care Costs, What They Are Saying

Rx News Roundup: New Drugs, Higher Prices

High-cost specialty drugs continue to fill drug pipeline, and with new FDA approvals come increased prices and increased spending. Continue reading

Posted in: Health Care Costs

New Issue Brief on Specialty Drug Issues and Challenges

A new issue brief from AHIP delves deeper into the challenges posed by high specialty drug pricing, which continues to threaten the availability of affordable coverage options for patients across the country. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

What’s behind health insurance premiums?

With recent discussions surrounding insurance premiums, it’s important to acknowledge an important fact: Premiums track directly with the underlying cost of care. Continue reading

Posted in: Health Care Costs

New Data Brief on Hospital Consolidation and Premiums

The growing body of evidence that hospital consolidation and higher premiums go hand-in-hand has yet another entry. A new AHIP data brief finds that as hospital consolidation increases, so too do premiums. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs